To confirm the downregulation of ELAVL3 observed transcriptionally and by immunofluorescence, we measured ELAVL3 protein levels by immunoblotting in sALS, C9, and SOD1 ALS cases (Fig. 4a). Here, ELAVL3 is linked to amyotrophic lateral sclerosis.